Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorman Broadb Regulatory News (NBB)

Share Price Information for Norman Broadb (NBB)

Share Price is delayed by 15 minutes
Get Live Data
194.00    0.00 (0.00%)
Bid:
190.00
Ask:
198.00
Spread: 8.00 (4.211%)
Market Cap: £3.60m
NBB Live PriceLast checked at - London Stock Exchange

Intraday Norman Broadb Share Chart

Trading Update

24 Jan 2023 07:00

RNS Number : 5985N
Norman Broadbent PLC
24 January 2023
 

Norman Broadbent plc

("Norman Broadbent", "NBB" or the "Group")

Trading Update

Norman Broadbent (AIM: NBB), a leading London quoted Executive Search and Interim Management firm offering a diversified portfolio of integrated Leadership Acquisition & Advisory Services, provides the following unaudited trading update for the three months ended 31 December 2022 ("Q4 2022") and the year ended 31 December 2022 ("FY22").

Q4 2022 Highlights

· Group Net Fee Income ("NFI") up 29% to £2.34m (Q4 2021: £1.81m)

· NFI up 40% compared to the average for the previous 3 quarters of £1.67m

· Edinburgh office established ahead of plan to bolster position in Scotland

· Sub-let over capacity in London office with income entirely offsetting cost in 2023 of newly opened Aberdeen and Edinburgh offices

 

FY22 Highlights

· NFI up 27% to £7.34m (FY 2021: £5.8m)

· Positive EBITDA expected to be approximately £100k, up c.£400k on FY 2021's LBITDA of £303k

· Highest expected annual NFI and EBITDA figures since FY 2019 and Company very much back to pre-pandemic levels

· Very positive run rate carry over from Q4 2022 into Q1 2023 with forward contracted revenue up 27% to £1.28m (Q1 2022: £1.01m)

Kevin Davidson, Group CEO of Norman Broadbent, commented:

"I am delighted with our Q4 2022 performance and the achievements of the team in 2022 as a whole. As planned, the Company generated positive annual EBITDA whilst also growing headcount significantly, thus building the platform for continued profitable growth in future years. This includes a number of fee generating hires made in Q4 2022 who will begin delivering revenue in Q1 2023. The quality and seniority of mandates has also been consistently rising over 2022 with the average fee per engagement increasing by 50% over that period. 

There has been significant change across the business over the past 18 months which has been driven and embraced by the entire team. We have very high levels of engagement and collective ambition for the future of Norman Broadbent.

We are aiming to deliver annual EBITDA of £1.25 million in 2025 through organic growth whilst continuing to seek acquisition opportunities. While the economic headwinds remain challenging, I am confident that the necessary foundations are in place to enable us to achieve this target."

For further information please contact:

Norman Broadbent plc

Kevin Davidson, CEO

Mehr Malik, CFO

 

+44 (0) 20 7484 0000

 

Shore Capital (Nominated Adviser and Broker)

Tom Griffiths / Tom Knibbs (Corporate Advisory)

Henry Willcocks (Corporate Broking)

+44 (0)20 7408 4090

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFERLFIVFIV
Date   Source Headline
20th May 202610:40 amRNSResult of AGM
20th May 20267:00 amRNSAGM Statement
8th May 20267:00 amRNSDirectorate Change
28th Apr 20265:25 pmRNSCourt Approval of Capital Reduction
22nd Apr 20267:00 amRNSPosting of Annual Report & Notice of AGM
21st Apr 20267:00 amRNSQ1 2026 Trading Update
20th Apr 20267:00 amRNSDirectorate Change
31st Mar 20269:11 amRNSTotal Voting Rights
26th Mar 20262:00 pmRNSResult of General Meeting
25th Mar 20267:00 amRNSFinal Results
18th Mar 20268:00 amRNSHolding(s) in Company
10th Mar 20267:00 amRNSProposed Capital Reduction
9th Mar 20269:23 amRNSReplacement- Results Notice/Investor Presentation
9th Mar 20267:00 amRNSNotice of Interim Results & Investor Presentation
25th Feb 20267:00 amRNSAcquisition And Total Voting Rights
6th Feb 20267:03 amRNSDirectorate Change
21st Jan 20267:00 amRNSDirectorate Change
15th Jan 20267:00 amRNSQ4 and FY25 Trading Update
13th Oct 20257:00 amRNSQ3 2025 Trading Update
9th Sep 20257:00 amRNSChange of Auditor
8th Sep 20257:00 amRNSInterim Results
19th Aug 20257:00 amRNSNotice of Interim Results & Investor Presentation
11th Aug 20257:00 amRNSAppointment of Nominated Adviser and Sole Broker
10th Jul 20257:00 amRNSH1 2025 Trading Update
19th Jun 20252:49 pmRNSNotification of major holdings
19th Jun 20257:00 amRNSDirector/PDMR Shareholding
16th Jun 20257:00 amRNSDirector/PDMR Shareholding
22nd May 202512:58 pmRNSResult of AGM, Capital Reorganisation and TVR
22nd May 20257:00 amRNSAGM Statement
22nd Apr 20257:00 amRNSPosting of ARA & Notice of AGM
2nd Apr 20257:00 amRNSQ1 2025 Trading Update and Final Results
4th Mar 20257:00 amRNSNotice of Results & Investor Presentation
16th Jan 20257:00 amRNSTrading Update
16th Oct 20247:00 amRNSQ3 2024 Trading Update
11th Oct 20244:00 pmRNSDirector/PDMR shareholding
8th Oct 20247:00 amRNSDirector/PDMR Shareholding
3rd Oct 20247:00 amRNSChange of Registered Office
9th Sep 20247:00 amRNSInterim Results
19th Aug 20247:00 amRNSNotice of Interim Results & Investor Presentation
22nd Jul 20243:46 pmRNSNotification of major holdings
11th Jul 20247:00 amRNSH1 2024 Trading Update
23rd May 20245:29 pmRNSResult of Annual General Meeting
25th Apr 20247:00 amRNSQ1 2024 Trading Update
24th Apr 20247:00 amRNSSmall Cap Awards nomination
15th Apr 20243:18 pmRNSNotification of major holdings
8th Apr 202412:11 pmRNSIssue of Equity and Total Voting Rights
3rd Apr 20244:01 pmRNSNotification of major holdings
28th Mar 20247:00 amRNSPosting of ARA & Notice of AGM
27th Mar 20247:00 amRNSFinal Results
26th Mar 20244:07 pmRNSNotification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.